Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epo-Omega once-weekly subcutaneous dose-dependency study in anaemic pre-dialysis CKD
2004-000676-13Phase 2Completed
- Sponsor
- Baxter
- Start
- Aug 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of epoetin omega in Uraemic Anaemia, sponsored by Baxter. Primary endpoint: Response rate. Started Aug 2004; status: completed.
02
Drugs
epoetin omega
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2004-000676-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000676-13.